首页> 外文期刊>Peptides: An International Journal >Desensitization and internalization of the human motilin receptor is independent of the C-terminal tail.
【24h】

Desensitization and internalization of the human motilin receptor is independent of the C-terminal tail.

机译:人胃动素受体的脱敏和内在化独立于C末端尾巴。

获取原文
获取原文并翻译 | 示例
       

摘要

The motilin receptor (MTLR) is an important therapeutic target for the treatment of hypomotility disorders but desensitization may limit its clinical utility. The aim of this study was to investigate the role of the C-terminal tail of the MTLR in the desensitization, phosphorylation and internalization process. Three MTLR mutants, C-terminally truncated from amino acid 412 till 384 (MTLRDelta385), 374 (MTLRDelta375) or 368 (MTLRDelta369), were constructed and C-terminally tagged with an EGFP and stably expressed in CHO cells co-expressing the Ca(2+) indicator apoaequorin. Activity and desensitization were studied by measuring changes in motilin-induced luminescent Ca(2+) rises. Receptor phosphorylation was investigated by immunoprecipitation and MTLR-EGFP internalization was visualized by fluorescence microscopy. Truncation only reduced MTLR affinity and the efficacy to induce Ca(2+) luminescent responses of the MTLRDelta375-EGFP mutant. Furthermore, the region between amino acid 375 and 368 seems to be important for proper cell surface expression of the MTLR since receptors of the MTLRDelta369-EGFP mutant but not of the other mutants were found intracellularly in vesicles. Truncation of the receptor till amino acid 384 or 374 did neither affect desensitization nor internalization. In contrast phosphorylation of the MTLRDelta385-EGFP mutant was reduced by 80% but was not affected in the MTLRDelta375-EGFP mutant. In conclusion, MTLR desensitization and internalization is not dependent on the presence of the C-terminal tail. Truncation favors internalization via either phosphorylation-independent pathways or via phosphorylation of alternative sites in the receptor.
机译:胃动素受体(MTLR)是治疗机动力减退性疾病的重要治疗靶标,但脱敏可能会限制其临床应用。这项研究的目的是研究MTLR的C末端尾巴在脱敏,磷酸化和内在化过程中的作用。构建了三个MTLR突变体,它们从氨基酸412到384(MTLRDelta385),374(MTLRDelta375)或368(MTLRDelta369)的C端被截短,并用EGFP进行C端标记并在共表达Ca( 2+)指示剂载脂蛋白。通过测量胃动素诱导的发光Ca(2+)上升的变化来研究活动和脱敏。通过免疫沉淀研究受体的磷酸化,并通过荧光显微镜观察MTLR-EGFP的内在化。截断只降低MTLR亲和力和诱导MTLRDelta375-EGFP突变体的Ca(2+)发光反应的功效。此外,氨基酸375和368之间的区域似乎对于MTLR的正确细胞表面表达很重要,因为在囊泡中的细胞内未发现MTLRDelta369-EGFP突变体的受体,而其他突变体的受体。截短受体直到氨基酸384或374都不会影响脱敏或内在化。相反,MTLRDelta385-EGFP突变体的磷酸化降低了80%,但在MTLRDelta375-EGFP突变体中未受影响。总之,MTLR脱敏和内在化并不取决于C末端尾巴的存在。截短有利于通过独立于磷酸化的途径或通过受体中替代位点的磷酸化进行内在化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号